Intensive care medicine: Challenges and opportunities in caring for critically ill
April 13–14th 2018, ICE Congress Centre Kraków, ul. Marii Konopnickiej 17
Download PDF
| April 13th 2018 (Friday) | |
|---|---|
| 9.00–9.15 | Opening ceremony |
| Session 1 | Sepsis and infections part 1 |
| Moderators: | Herwig Gerlach, Berlin ; Małgorzata Mikaszewska-Sokolewicz, Warszawa |
| 9.15–9.35 | The new Sepsis Definitions – so what’s new?
Mervyn Singer, London, UK |
| 9.35–9.55 | Steroids in sepsis and septic shock – an update Herwig Gerlach, Berlin, Germany |
| 9.55–10.15 | Immunoglobulins in severe community-acquired pneumonia Manu Shankar-Hari London, UK |
| 10.15–10.40 | Discussion |
| 10.40–11.10 | Coffee break |
| Session 2 | Extracorporeal life suport – an update |
| Moderators: | Alain Combes, Paryż ; Konstanty Szułdrzyński, Kraków |
| 11.10–11.30 | Current evidence for VV-ECMO Alain Combes, Paris, France |
| 11.30–11.50 | Current evidence for ECCO2R Daniel Brodie, New York, USA |
| 11.50–12.10 | Current evidence for e-CPR Martin Balik, Prague, Czechia |
| 12.10–12.30 | Discussion |
| Session 3 | Mechanical ventilation part 1 |
| Moderators: | Giuseppe Foti, Monza ; Tomasz Łazowski, Warszawa |
| 12.30–12.50 | A patient – ventilator interaction and synchronization Francesco Mojoli, Pavia, Italy |
| 12.50–13.10 | Transpulmonary pressure measurement in mechanical ventilation Francesco Mojoli, Pavia, Italy |
| 13.10–13.25 | Discussion |
| 13.25–14.10 | Lunch |
| Session 4 | Sepsis and infections part 2 |
| Moderators: | Herwig Gerlach, Berlin ; Małgorzata Mikaszewska-Sokolewicz, Warszawa |
| 14.10–14.40 | Lactate clearance in sepsis Manu Shankar-Hari London, UK |
| 14.40–15.00 | The role of beta-blockade in sepsis Mervyn Singer, London, UK |
| 15.00–15.20 | Absorbtion techniques in sepsis: evidence and clinical practice Frank Brunkhorst, Jena, Germany |
| 15.20–16.00 | Improving outcomes in septic shock: optimizing antimicrobial therapy Anand Kumar, Winnipeg, Canada |
| 16.00–16.20 | Discussion |
| 16.20–16.40 | Coffee break |
| Session 5 | Ethical, legal and human aspects of intensive therapy (Polish) |
| Moderators: | Rafał Niżankowski, Kraków ; Wojciech Serednicki, Kraków |
| 16.40–17.10 | Patient’s right to intimacy in the ICU Rafał Kubiak, Łódź, Poland |
| 17.10–17.40 | Interpersonal communication issues in the ICU Maria Nowina-Konopka, Kraków, Poland |
| 17.40–18.00 | Discussion |
| 18.00 | Cocktail |
| April 14th 2018 (Saturday) | |
| Session 6 | Haemodynamics |
| Moderators: | Martin Balik, Praga ; Xavier Monnet, Paryż |
| 9.00–9.20 | Venous return: from physiology to the bedside Xavier Monnet, Paris, France |
| 9.20–9.40 | Novelties in the management of circulatory failure Alexandre Mebazaa, Paris, France |
| 09.40–09.55 | Discussion |
| 09.55–10.20 | Coffee break |
| Session 7 | Continuous renal-replacement |
| Moderators: | Torsten Slowinski, Berlin ; Mirosław Czuczwar, Lublin |
| 10.20–10.40 | Individualization of CRRT in critically ill Torsten Slowinski, Berlin, Germany |
| 10.40–11.00 | Choice of anticoagulation in CRRT Martin Balik, Prague, Czechia |
| 11.00–11.15 | Discussion |
| 11.15–11.40 | Coffee break |
| Session 8 | Mechanical ventilation part 2 |
| Moderators: | Giuseppe Foti, Monza ; Konstanty Szułdrzyński, Kraków |
| 11:40–12:00 | Individualization of mechanical ventilation in ARDS: the role of FRC Giuseppe Foti, Monza, Italy |
| 12.00–12.20 | Weaning failure of cardiac origin Xavier Monnet, Paris, France |
| 12.20–12.40 | Partial Ventilatory Support during ARDS: always or never? Giuseppe Foti, Monza, Italy |
| 12.40–13.00 | Discussion |
| 13.00–13.50 | Lunch |
| Session 9 | Patient’s outcome after intensive care |
| Moderators: | Daniel Brodie, Nowy Jork ; Wojciech Serednicki, Kraków |
| 13.50–14.10 | ICU-acquired cognitive impairment Tarek Sharshar Paris, France |
| 14.10–14.30 | Early physiotherapy in ICU patients Daniel Brodie, New York, USA |
| 14.30–14.50 | ICU-acquired weakness Tarek Sharshar Paris, France |
| 14.50–15.05 | Discussion |
| 15.05–15.30 | Coffee break |
| Session 10 | Intensive care medicine in Poland part 1 (Polish) |
| Moderators: | Tomasz Łazowski, Warszawa ; Miłosz Jankowski, Kraków |
| 15.30–15.50 | Intensive care medicine in 2018 roku – what’s new in in guidelines and research? Miłosz Jankowski, Kraków, Poland |
| 15.50–16.10 | The role of biochemical markers in the assessment of antimicrobial treatment efficacy Małgorzata Mikaszewska-Sokolewicz, Warszawa, Poland |
| 16.10–16.25 | Discussion |
| Session 11 | Intensive care medicine in Poland part 2 (Polish) |
| Moderators: | Rafał Niżankowski, Kraków ; Waldemar Goździk, Wrocław |
| 16.25–16.45 | Multimodal therapy of cardiac shock Waldemar Goździk, Wrocław, Poland |
| 16.45–17.05 | Acinetobacter baumanii infections – prevention and treatment Małgorzata Fleischer, Wrocław, Poland |
| 17.05–17.25 | How to adjust other treatments to the renal-replacement therapy Mirosław Czuczwar, Lublin, Poland |
| 17.25–17.40 | Intensive care without walls – Rapid Response Teams in Polish hospitals Roman Jaeschke, Hamilton, Canada ; Konstanty Szułdrzyński, Kraków, Poland |
| 17.40–18.00 | Discussion |
| 18.00 | Closing ceremony |
Scientific committee
prof. dr hab. med. Rafał Niżankowski
prof. dr hab. med. Jerzy Wordliczek
dr n. med. Miłosz Jankowski
dr n. med. Małgorzata Mikaszewska-Sokolewicz
dr n. med. Wojciech Serednicki
dr n. med. Konstanty Szułdrzyński
Steering committee
dr n. med. Konstanty Szułdrzyński
dr n. med. Miłosz Jankowski
dr Anna Wierzchowska-Woźniak
